Atacicept met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a ...

Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the ...

DISP-10 is a novel tumor-specific virus and CAR T combination designed to overcome key challenges of applying CAR T therapy to solid tumors DISP-10 has broad potential to target all solid tumors of ...

Tech firms are floating the idea of building data centers in space and tapping into the sun's energy to meet ...

RIDE-001 was developed using Trained Therapeutix’s proprietary ApoA1-based nanomedicines platform to target the bone marrow where it activates the intracellular pattern recognition receptor NOD2. This ...

As Nancy Pelosi steps down from Congress, Indian-origin Democrat Saikat Chakrabarti is emerging as one of the prominent ...

Delhi Environment Minister Manjinder Singh Sirsa on Monday rejected the claims that the data containing records of Delhi’s real Air Quality Index were tampered with, saying the information furnished ...

Australia announces the "Solar Sharer" program for free daily power. All households will benefit, driving major changes in ...

Vera Therapeutics (VERA) announced data from the ORIGIN Phase 3 trial of atacicept in IgA nephropathy were presented as a featured late-breaking ...

Surya Ganguli, Surbhi Goel and Krishna Pillutla among scholars to receive $18 million in AI2050 fellowships for AI research ...

The latest research adds a dimension of clarity to sea otter health. So do new discoveries about the ways to treat ...

In Texas, which has the second-largest population of immigrants living illegally in the country — with more than 1.6 million ...